Physician profile
Paul E Mitchell
NPI 1033201629
$1,191.08
in general payments reported to CMS, 2019-2025
19 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $18.92 · 2022: $86.60 · 2023: $229 · 2024: $381 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $793.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $256.42 | 2022-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $166.36 | 2019-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $115.81 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Sanofi Pasteur INC. | $79.67 | 2022-2025 | |
| Pfizer INC. | $78.98 | 2019-2025 | |
| Glaxosmithkline, LLC. | $64.89 | 2019-2025 | Bexsero |
| Shire North American Group INC | $63.96 | 2019 | |
| Sobi, INC | $59.23 | 2023-2024 | |
| Cipher Pharmaceuticals US LLC | $50.33 | 2025 | Natroba, Spinosad |
| Astrazeneca Pharmaceuticals Lp | $49.02 | 2023-2024 | Flumist Quadrivalent |
| Alk-Abello, INC | $42.28 | 2023 | Grastek, Ragwitek, Odactra |
| Cranial Technologies, INC | $28.63 | 2019-2022 | |
| Corium, LLC | $27.91 | 2025 | Azstarys |
| Phadia US INC. | $20.42 | 2023 | Immunocap |
| Vertical Pharmaceuticals, LLC | $19.63 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $19.63 | 2025 | Ycanth |
| Seqirus USA INC | $19.12 | 2023 | Flucelvax Quadrivalent |
| Novartis Pharmaceuticals Corporation | $15.85 | 2019 | |
| Tris Pharma INC | $12.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.